Navigation Links
Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
Date:10/30/2007

ergy inspires clinical confidence to undertake advanced radiation therapy techniques such as Intensity Modulated Arc Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).

Upgrades for even more efficient stereotactic workflow with Elekta Synergy will be displayed at ASTRO. Medical Intelligence, an Elekta company, will display the non-invasive HeadFIX(R) and BodyFIX(R) patient-specific immobilization devices, which are vacuum-activated for highly accurate and reproducible positioning and immobilization. Elekta is showing three new micro multileaf collimators (MLCs), the most versatile technology available for SRS and SRT. All three micro MLCs - the 3mm, the 5mm and the 7mm leaf width - have improved dose shaping abilities for minimal risk to critical organs.

Illustrious history, solid future in stereotaxy

"Elekta's stereotactic products demonstrate its commitment to technological innovation and advances in stereotaxy," says Puusepp. Elekta was founded by the late professor Lars Leksell, a pioneer in minimally invasive surgery and inventor of the Leksell Stereotactic System(R) in 1948 and Leksell Gamma Knife in 1968. Since, Elekta has continued to set new standards in accuracy and therapeutic efficacy in both stereotactic radiation therapy and stereotactic radiosurgery.

"As Elekta develops high quality cost-effective solutions, cancer centers around the world are taking a major interest in adding whole-body radiosurgery to their radiation therapy capabilities," says Puusepp.

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.

Elekta's systems and solutions are used in over 4,500 hospital
'/>"/>

SOURCE Elekta, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Life-sciences conference showcases capital ideas of Wisconsin
2. Modine showcases CO2 cooled Jeep
3. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
4. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
5. Performance Comparisons of Commercial RT-PCR Systems
6. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
7. In Vivo Signal Transduction Pathway Reporting Systems
8. Improved Vectors for PathDetect Trans-Reporting Systems
9. Genetic Reporter Systems
10. Genetic Reporter Systems
11. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... ITGI Medical, Ltd.,(TASE: ITGI) a company engaged ... covered stents, announced that the US Food,and Drug ... to Over and Under(R) and Aneugraft(R) Pericardium Covered ... coronary arteries and,Saphenous Vein Grafts. , ...
... Md., April 28 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, announced today that results ... presented yesterday at the 12th Annual Conference on Vaccine ... The conference is sponsored by the National Foundation of ...
... Yesterday Bavarian Nordic Announced its Interim Results for ... in the Biodefence and Cancer Business Areas , ... of,IMVAMUNE(R) , - Preparations for the Delivery of ... - PROSTVAC(TM) Data Have Been Accepted for an Oral Presentation at ...
Cached Biology Technology:PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 2PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 4PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 5PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 6PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 7Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009 2Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009 3Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009 4
(Date:4/23/2014)... and German . ... mammals, the difference between sexes depends on one single element of ... where the two sexual chromosomes are X and Y, whereas women ... all the morphological and physiological differences between males and females. , ... time ago, the X and Y were identical, until the Y ...
(Date:4/23/2014)... Wash. -- Like a hungry diner ripping open a ... into electricity must tear open a hydrogen molecule. Now ... holding onto the two halves of its hydrogen feast. ... how to make the catalyst work better for alternative ... scientists have shown precisely where the hydrogen halves end ...
(Date:4/23/2014)... and Spanish . ... released its Conservation Assessment for the Big Bend-Ro Bravo ... 29 priority conservation areas in a region straddling the ... in the states of Texas, Coahuila, and Chihuahua. This ... inhabited by rare and endangered plants and animals, and ...
Breaking Biology News(10 mins):Male or female? 2Male or female? 3Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Conservation priorities released for several protected areas along US-Mexico border 2Conservation priorities released for several protected areas along US-Mexico border 3
... Athene Donald has won the Science and Technology award ... honor to Professor Donald, Glamour magazine praised her as a ... real path for herself in the male-dominated world of physics." ... Physics at the University of Cambridge in the United Kingdom ...
... CAA researcher at Charles Drew University of Medicine and Science ... a promising, natural therapy for cancer. Dr. Mamdooh Ghoneum ... on "Cell Death Mechanism," sponsored by the American Association for ... San Diego. "The central focus of the meeting ...
... RIVERSIDE, Calif. Stem cell research at the University of ... establishment of a new Stem Cell Core Facility (SCCF) ... doing stem cell research that ordinarily would not be available ... Noel Keen Hall, had its grand opening on Friday, Jan. ...
Cached Biology News:Charles Drew cancer studies with yeast yield excellent results 2UC Riverside's new state-of-the-art technology to accelerate stem cell research 2
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Request Info...
Biology Products: